Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?

Cloning is commonly perceived as a means of generating genetically identical individuals, but it can also be used to obtain genetically matched embryo-derived stem cells, which could potentially be used in the treatment of patients. A recent report offers the first 'proof of principle' of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjantonakis, Anna-Katerina, Papaioannou, Virginia E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139399/
https://www.ncbi.nlm.nih.gov/pubmed/12186652
_version_ 1782120565901885440
author Hadjantonakis, Anna-Katerina
Papaioannou, Virginia E
author_facet Hadjantonakis, Anna-Katerina
Papaioannou, Virginia E
author_sort Hadjantonakis, Anna-Katerina
collection PubMed
description Cloning is commonly perceived as a means of generating genetically identical individuals, but it can also be used to obtain genetically matched embryo-derived stem cells, which could potentially be used in the treatment of patients. A recent report offers the first 'proof of principle' of such cloning for therapeutic purposes, referred to as nuclear transplantation to produce stem cells for autologous transplantation.
format Text
id pubmed-139399
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1393992003-03-04 Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases? Hadjantonakis, Anna-Katerina Papaioannou, Virginia E Genome Biol Minireview Cloning is commonly perceived as a means of generating genetically identical individuals, but it can also be used to obtain genetically matched embryo-derived stem cells, which could potentially be used in the treatment of patients. A recent report offers the first 'proof of principle' of such cloning for therapeutic purposes, referred to as nuclear transplantation to produce stem cells for autologous transplantation. BioMed Central 2002 2002-07-30 /pmc/articles/PMC139399/ /pubmed/12186652 Text en Copyright © 2002 BioMed Central Ltd
spellingShingle Minireview
Hadjantonakis, Anna-Katerina
Papaioannou, Virginia E
Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
title Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
title_full Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
title_fullStr Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
title_full_unstemmed Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
title_short Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
title_sort can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases?
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139399/
https://www.ncbi.nlm.nih.gov/pubmed/12186652
work_keys_str_mv AT hadjantonakisannakaterina canmammaliancloningcombinedwithembryonicstemcelltechnologiesbeusedtotreathumandiseases
AT papaioannouvirginiae canmammaliancloningcombinedwithembryonicstemcelltechnologiesbeusedtotreathumandiseases

Ejemplares similares